A photocatalytic method for producing chlorine dioxide (ClO2), a non-toxic antimicrobial, from inexpensive sodium chlorate (NaClO3) under UV and visible light. Uses semiconductor-based photocatalysts to enable on-demand, ambient-condition ClO2 generation for disinfection applications.
Chlorine dioxide (ClO2) is a well-established, non-toxic antimicrobial molecule widely used for disinfection. This research proposes a photocatalytic approach to produce ClO2 on demand under ambient conditions using inexpensive reagents, specifically sodium chlorate (NaClO3) as the chlorine source. By leveraging semiconductor-based photocatalysts activated under UV and visible light, excited electrons with sufficient reducing power are generated to convert NaClO3 into ClO2. This method offers a potentially low-cost, light-driven alternative to conventional ClO2 production routes, enabling decentralized and sustainable generation of this important disinfectant for water treatment, food safety, healthcare, and other antimicrobial applications.
Core approach:
Photocatalyst library and capabilities:
Optimization parameters:
This is an early-stage research concept at Technology Readiness Level 1–2 (basic principle observed and technology concept formulated). The hypothesis has not yet been experimentally tested in the laboratory. The research group brings strong prior expertise in photocatalytic transformations and semiconductor photocatalyst synthesis, which supports confidence in feasibility. The planned validation pathway begins with measuring the reduction potential of NaClO3 under application-relevant conditions, followed by catalyst design and synthesis, ClO2 quantification, and systematic optimization of production rate. The laboratory is well equipped for both materials synthesis and photocatalytic studies, enabling rapid hypothesis testing.
The University of Cincinnati is a comprehensive public research university with an applied, urban-serving character and a significant clinical enterprise. Industry engages through one of the nation's largest cooperative education programs, placing students year-round with corporate R&D and operations teams and creating an on-ramp to sponsored research. An innovation district near campus hosts co-located corporate labs, startup space, and shared prototyping facilities, while the university's integration with a major hospital system enables clinical studies and translation. Research is supported by competitive federal funding from agencies such as NIH and NSF, along with state and industry partnerships. A dedicated technology transfer office manages IP, licensing, corporate agreements, and startup formation, providing flexible models for collaboration.